Further, CCK-8 assays showed that overexpression of ABI3BP led to a significant decrease in cell viability in both NSCLC cell lines compared to the control and ad-NC groups (Figure 2b). The gene discussed is ABI3BP; the disease is non-small cell lung carcinoma.